Once-daily ropinirole

Requip XL tablets (ropinirole prolonged release) offer a once-daily dosing schedule for the treatment of idiopathic Parkinson's disease in patients already taking ropinirole immediate-release tablets in whom adequate symptomatic control has been established.

Requip XL may be used alone (without levodopa) or in addition to levodopa to control ‘on-off’ fluctuations which might permit a reduction in the total daily dose of levodopa.

Substitution of Requip XL from ropinirole immediate-release tablets should be supervised by appropriate specialists in Parkinson’s disease.

View Requip XL drug record

Further information: GlaxoSmithKline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

PHE issues coronavirus guidance for primary care

PHE issues coronavirus guidance for primary care

Public Health England (PHE) has issued guidance for...

HPV infections fall dramatically but researchers say vaccine efficacy is 'uncertain'

HPV infections fall dramatically but researchers say vaccine efficacy is 'uncertain'

Cancer-causing HPV16 and 18 infections are now 'extremely...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Drug shortages - live tracker

Drug shortages - live tracker

Added: Adcal D3 Dissolve, Diamox SR, flumetasone/clioquinol,...